Teva Pharmaceutical Industries Ltd. on Wednesday won regulatory approval from the Federal Trade Commission for its acquisition of Allergan PLC’s generics business, conditioned upon Teva’s divestiture of 75 drugs to rivals.
from WSJ.com: US Business http://ift.tt/2argwFx
via IFTTT
No comments:
Post a Comment